16.55

0.66% -0.11

Lyell Immunopharma Inc (LYEL)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Lyell Immunopharma Inc-Aktie (LYEL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	14.29% 0.008	0.007	0.011	0.034	0.013
Operating Expenses	17.82% 47.15	57.37	201.16	50.54	51.54
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	17.82% 47.15	57.37	201.16	50.54	51.54
Operating Income/Loss	17.83% -47.14	-57.37	-201.15	-50.51	-51.53
Nonoperating Income/Loss	13.84% 4.456	5.172	9.212	5.922	5.719
Income/Loss From Continuing Operations Before Tax	14.29% 0.008	0.007	0.011	0.034	0.013
Income/Loss From Continuing Operations After Tax	18.22% -42.68	-52.20	-191.94	-44.58	-45.81
Net Income/Loss	18.22% -42.68	-52.20	-191.94	-44.58	-45.81
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	94.99% 14.79	295.10	6.157	256.31	255.40
Diluted Average Shares	94.99% 14.79	295.10	6.157	256.31	255.40
Basic Earnings Per Share	1,506% -2.89	-0.18	-0.72	-0.17	-0.18
Diluted Earnings Per Share	1,506% -2.89	-0.18	-0.72	-0.17	-0.18
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.30

0.64%

GMAB

$28.71

0.35%

INCY

$101.57

8.65%

BNTX

$103.95

0.04%

ONC

$311.86

0.44%

INSM

$186.23

1.78%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters